- 8%

XYMOGEN K2-D3 10000 – Vitamin D3 K2 – Bioavailable Vitamin D 10,000 IU (Cholecalciferol) with Vitamin K2 MK-7 – Heart, Arterial, Bone Health + Immune Support Supplement (60 Capsules)

Add to wishlistAdded to wishlistRemoved from wishlist 0

Original price was: $36.00.Current price is: $32.99.

Category:

XYMOGEN K2-D3 10000 – Vitamin D3 K2 – Bioavailable Vitamin D 10,000 IU (Cholecalciferol) with Vitamin K2 MK-7 – Heart, Arterial, Bone Health + Immune Support Supplement (60 Capsules)

Bioavailable Format – Xymogen Vitamin D3 K2 contains vitamin K2 (MK7 vitamin k2) and vitamin D3 10000 IU in its most bioavailable form for superior absorption.
Supports Healthy Bones – Our K2 vitamin supplement is formulated to support bone health, by promoting the carboxylation of bone proteins. Supports cardiovascular health by affecting arterial calcium deposits.*
The Most Bioactive Form Available – This vitamin d with k2 features the most bioactive form of supplemental vitamin K2 available and the d3 vitamin (as cholecalciferol). Unlike some vitamin d supplements, this vit D3 format is identical to the vitamin D derived in the body and synthesized by sunlight on the skin.*
Clinical Proven – Clinical studies have confirmed that combining vitamin d with k2 can help create synergistic, supportive bone supplements and heart health supplements.*
K2 D3 vitamin supplement formulated to exclude – Wheat, gluten, yeast, soy protein, dairy products, fish. shellfish. peanuts, tree nuts, egg, ingredients derived from GMOs, and artificial preservatives. This vitamin d k2 formula contains vit d derived from animal-derived ingredients.

User Reviews

0.0 out of 5
0
0
0
0
0
Write a review

There are no reviews yet.

Be the first to review “XYMOGEN K2-D3 10000 – Vitamin D3 K2 – Bioavailable Vitamin D 10,000 IU (Cholecalciferol) with Vitamin K2 MK-7 – Heart, Arterial, Bone Health + Immune Support Supplement (60 Capsules)”

Your email address will not be published. Required fields are marked *

Willowwilde
Logo
Shopping cart
Verified by MonsterInsights